Rett syndrome hits hard and early, but with Neuren’s Daybue and Neurotech’s cannabis-based NTI164 building steam, the fight ...

Australia’s S&P/ASX 200 rose 2.36% in July, posting gains of almost 9% so far for CY25 with health care rebounding 9% for ...

It’s no easy gig analysing share prices and company performance but somebody’s got to do it. This week, two experts eye up PLS, CMW and more.

Australia has more national parks than any other country in the world. Whether you hit the trail, take flight or head out on ...

Small cap stocks should be big winners from rate reductions, partly because they are more exposed to sectors that benefit ...

The US-centred critical minerals strategy of Locksley Resources has been validated by a heavily oversubscribed $5.3 million ...

These unassuming Queensland ASX explorers have been quietly building momentum at their resources projects during the June ...

This expert has been a financial adviser for more than 20 years and here are the things he's noticed that his wealthiest clients tend to do.

“These latest results continue a steady stream of new discoveries that highlight the broader potential of Minyari Dome, with ...

The pace of innovation in battery storage technology is advancing in lock step with its adoption, here are some promising ...

Investors looking only at the surface of the Fed's latest decision risk missing what really matters, writes Nigel Green.

Today's crop of last minute quarterly 'homework' isn't hiding too much of the nasty stuff synonomous with 'just-in-time' ...